Britain says Canada's Concordia overcharging health service for thyroid drug
November 21, 2017 at 04:47 AM EST
LONDON, Nov 21 (Reuters) - Drug company Concordia overcharged Britain's health service millions of pounds for an essential thyroid drug by abusing its position as the only supplier, the country's Competition and Markets Authority said on Tuesday.
